Large-scale CRISPRi chemical genetic screening in Mycobacterium tuberculosis identifies genes altering antibiotic potency and the repurposing of the antibiotic clarithromycin to treat tuberculosis in Southeast Asia.
References
Li, S. et al. Nat. Microbiol. https://doi.org/10.1038/s41564-022-01130-y (2022).
Schnappinger, D. Cold Spring Harb. Perspect. Med. 5, a021139 (2015).
Schnappinger, D. & Ehrt, S. Microbiol. Spectr. 2, MGM2-0018-2013 (2014).
Bosch, B. et al. Cell 184, 4579–4592.e24 (2021).
Choudhary, E. et al. Nat. Commun. 6, 6267 (2015).
Singh, A. K. et al. Nucleic Acids Res. 44, e143 (2016).
Larrouy-Maumus, G. et al. ACS Infect Dis. 2, 352–360 (2016).
Gorla, P. et al. Front. Microbiol. 9, 2839 (2018).
Arenz, S. & Wilson, D. N. Cold Spring Harb. Perspect. Med. 6, a025361 (2016).
Burian, J. et al. Expert Rev. Anti. Infect. Ther. 10, 1037–1047 (2012).
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Competing interests
The author declares no competing interests.
Rights and permissions
About this article
Cite this article
de Carvalho, L.P.S. Gene–drug potency screening in M. tuberculosis. Nat Microbiol 7, 743–744 (2022). https://doi.org/10.1038/s41564-022-01139-3
Published:
Issue Date:
DOI: https://doi.org/10.1038/s41564-022-01139-3
- Springer Nature Limited